STING1 and breast cancer: Notably, knocking down STING in 4T1 tumor cells led to a 2.28-fold reduction in IFN-β secretion in “BC@Z-M + L” group, while STING overexpression further amplified IFN-β secretion (Supplementary Fig. 37).